Bratha

Part 2.1 — The Internal Stack and the Procedures

6 min read

This is Part 2.1 in the Skin series. The full path:

Framing — this is the deep end

Part 2.0 was what you put on skin. This is what you put in the body and what a machine does to skin. It runs from harmless (collagen, omega-3) to genuinely serious (oral isotretinoin, growth hormone) to clinical (lasers, RF).

==Everything past the supplement tier requires bloodwork and a physician — non-negotiable, the same stance as Protection and When the Numbers Move in the Performance-Enhancement series.== Oral isotretinoin is teratogenic and hits lipids/liver; GH carries the full PE-series caveat load. Nothing here is medical advice, and per house convention there are no doses for prescription or research compounds — only for OTC supplements.

Table of Contents

Planned TOC — scaffold stage

Locked spine below; prose written in the drafting pass.

Working notes — Part 2.1 build plan (trim before publishing)

Section spine to expand in drafting. House format from Part 1.1’s checklist. This is the article that ties the Skin series into the Performance-Enhancement machinery.

The three internal layers. Frame the article: (1) ingestibles anyone can run, (2) the enhanced tier (Rx/grey-market, bloodwork-gated), (3) procedures (clinic energy-based). Same risk-laddering logic as the PE series’ tier structure.

Tier 1 — the ingestible stack (mechanism → use → OTC dose ranges OK here):

  • Collagen peptides 10–20 g/day + vitamin C (cofactor) — Bryan runs 20–30 g; evidence for elasticity/hydration is real but modest. Pair logic.
  • Omega-3 (EPA/DHA) — barrier lipids, anti-inflammatory, membrane quality.
  • Niacinamide (oral) — NAD⁺ precursor; photoprotection signal; ties to the topical niacinamide in 2.0.
  • Antioxidants / polyphenols — astaxanthin, polypodium leucotomos (oral photoprotection — useful in the tropics), resveratrol; the Blueprint “polyphenols + antioxidants” line.
  • Vitamin D / zinc — barrier + acne + general (zinc esp. for acne-prone).
  • Cross-link the future /healthy/nutrition note for the glycation/diet angle (same forward-reference Fit 5.0 uses; note it’s not built yet).

The enhanced tier — accutane, GHK-Cu, GH (the “what else” Nadeem flagged; Rx/grey-market; bloodwork-gated; NO doses for these):

Microdose oral isotretinoin (accutane). The big one from Nadeem’s seed. Mechanism: shrinks sebaceous glands → sebosuppression → “poreless/glass skin,” durable acne control; emerging low-dose anti-aging use. Honest harm-reduction: ==teratogenic (absolute contraindication in pregnancy), dyslipidaemia + transaminase rise (→ lipid panel + LFTs, the exact markers tracked in When the Numbers Move)==, mucocutaneous dryness, mood signal (monitor), sun sensitivity (collides with the tropical UV load — flag hard), impaired wound healing (don’t stack with microneedling/lasers/waxing — interacts with the procedures section below). Frame as a microdose / low-cumulative-dose strategy, physician-run.

GHK-Cu (injectable copper peptide). The systemic counterpart to the topical GHK-Cu in 2.0 — Nadeem’s Protocol.md seed, injectable side. Mechanism: copper-tripeptide → collagen/elastin synthesis, wound healing, antioxidant; subq. Grey-market QC + sterility caveats. Cross-link the GHK-Cu already described in Hair 2.0 to avoid re-teaching.

Growth hormone and secretagogues. The other Protocol.md seed (HGH). Mechanism: GH/IGF-1 → dermal thickness, collagen, healing → the “GH glow.” But full PE-series caveat load: IGF-1, glucose/insulin resistance, water retention, tissue overgrowth — defer the systemic-risk detail to the PE series rather than re-teaching. MK-677 (oral secretagogue) is already covered in Hair 2.0 — cross-link, note its skin/hydration crossover. Honest verdict: GH for skin alone is a poor risk/reward; it’s a side-benefit for those already running it for PE reasons.

Bloodwork — the same arbiter. Lipid panel + LFTs for isotretinoin; IGF-1 + fasting glucose/HbA1c for GH. ==Reuse the marker-hierarchy and “the number is the boss” framing from Part 4.1== rather than rebuilding it — one short table + cross-link. Malaysian labs (BP Healthcare/Gribbles/Pathlab).

The procedures ladder (low → high intensity; mechanism → what it treats → cadence → downtime/risk). Mirror the Hair 2.0 “mechanical & environmental” section:

  • Red light therapy (LLLT) — mitochondrial/collagen; Bryan’s daily 6-min; at-home panels/masks; cheap, low-risk entry.
  • Microneedling (dermaroller/stamp/pen) — collagen induction; do NOT run on isotretinoin (healing) — explicit interaction callout; PIH risk on darker skin → conservative depth.
  • Chemical peels — superficial (glycolic/salicylic, at-home-ish) → medium (TCA, clinic); PIH risk Fitzpatrick III–V → flag.
  • Lasers — Bryan’s 1927 nm (surface: tone, texture, dyschromia, sun damage, fine lines) and 1550 nm (deeper: firmness, wrinkles, scars). ==Darker-skin laser caution is the dominant Malaysian-audience point — wrong device/settings on III–V = burns + hyperpigmentation; need an operator experienced with Asian skin.==
  • RF & ultrasound — Everesse (monopolar RF, lifting/tightening), Sofwave (focused ultrasound, collagen); ~1×/6 months per Bryan; safer across skin tones than ablative lasers (energy not light → less melanin-targeting). Possibly fold the medicube at-home RF/microcurrent device here (decided from 2.0’s open item).
  • Note the botox/filler boundary — wrinkle masking and volume vs skin quality; this series owns quality, names the line, defers injectable-aesthetics detail (Appearance/aging adjacency).

Putting the inside-out protocol together. A tiered “where to start” summary: lock 2.0 topicals + SPF + Tier 1 ingestibles first; add RLT (cheap); consider isotretinoin only with a derm + bloodwork; lasers/RF as periodic clinic maintenance; GH/GHK-Cu only if already in the PE world. Echo the Fit 5.0 “worked example / order of operations” device.

Open items

  • Half of Protocol.md lands here (injectable GHK-Cu + HGH); coordinate the stub-deletion with Part 2.0 (delete once both drafted, confirm with Nadeem).
  • Decide depth of GH section — probably keep it short and lean hard on cross-links to the PE series to avoid duplicating that whole risk apparatus here.
  • Melanotan (tan as a look) — boundary item; Appearance owns the aesthetic dial, this series only notes the pigmentation/health angle (per the 1.1 boundary map). Confirm placement.

Graph View

Backlinks